Latest filing published 06 Mar 2026 for Quest Diagnostics INC, €2.0M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Catherine T. Doherty in Quest Diagnostics Inc, where the filings describe the role as senior executive. Between 7 May 2021 and 4 March 2026, the trades on record add up to 24 filings.
No open-market purchase appears, only 5 sales worth €2.4M. Outside the open market, there are 15 share grants and 4 option exercises.
The record was last updated on 6 March 2026 with a share grant (€2.0M) in Quest Diagnostics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations